ArticleActa parasitologica2026
Toxoplasma GRA72 is Involved in Membrane-Associated Functions and Metabolic Homeostasis Revealed by Transcriptomic Analysis.
Article in Acta parasitologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundToxoplasma gondii is a widely disseminated obligate intracellular parasite, infecting approximately one-third of the world human population. While infections in healthy individuals are typically asymptomatic or mild, the parasite poses a serious threat to specific populations. Immunocompromised individuals (such as AIDS patients and organ transplant recipients) risk life-threatening toxoplasmic encephalitis, and congenital infection during pregnancy can lead to fetal loss or severe neurological and ocular defects in newborns. GRA72, one of the dense granule proteins secreted by T. gondii, is known to localize to the parasitophorous vacuole membrane (PVM) and parasitophorous vacuole (PV). Though important for PVM permeability, PV morphology, tachyzoite growth, and virulence, GRA72’s imapct on the global parasite transcription and its potential interacting or compensatory proteins remains unclear.
methodHigh-throughput RNA sequencing (RNA-seq) was performed on the pre-constructed T. gondii GRA72 gene knockout strain (PruΔgra72) and wild-type Pru strain to compare differences in global gene expression. Differentially expressed genes (DEGs) were identified and subjected to functional annotation and pathway enrichment analysis. Gene Ontology (GO) enrichment analysis were conducted based on GO annotation and the standard classification system. The Kyoto Encyclopedia of Genes and Genomes (KEGG) database was utilized to identify major metabolic and signaling pathways associated with these DEGs. RNA-seq results were verified by quantitative reverse transcription polymerase chain reaction (RT-qPCR).
resultsRNA-seq analysis identified 858 DEGs in PruΔgra72 strain compared to the wild-type strain, comprising 550 upregulated and 308 downregulated. Upregulation of bradyzoite associated genes were observed in PruΔgra72, while expression of dense granule proteins (GRAs) exhibited bidirectional regulation. RT-qPCR analysis validated the RNA-seq data. GO enrichment analysis revealed significantly enrichment of DEGs in membrane-related functional categories. KEGG pathway analysis indicated that the DEGs were significantly enriched in key metabolic pathways, including fatty acid, carbon and amino acid metabolism.
conclusionThis study provide a new perspective for studying the pathogenic mechanisms of T. gondii, revealing that GRA72 modulates membrane-associated functions and metabolic homeostasis. The observed transcriptional changes, particularly the upregulation of bradyzoite genes and altered expression of GRAs, suggest that GRA72 may play an important role in parasite development. Further investigation of the compensatory or interacting upstream/downstream genes associated with membrane function and reprogrammed metabolism (fatty acid, carbon, amino acid) will elucidate GRA72’s molecular mechanisms and could facilitate the development of novel anti-Toxoplasma therapeutics.
Indexed as
Identifiers
42068418What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.